The Joint Council for Cosmetic Practitioners (JCCP), was formally launched In February 2018 as a ‘self-regulating’ body for the non-surgical aesthetics and hair restoration sector in the United Kingdom and has achieved Professional Standards Authority (PSA) recognition and charitable status. The charitable status reflects the overarching not-for-profit mission of the JCCP which is to improve patient safety and public protection. The concept of the JCCP was envisioned by the Department of Health and was inspired by Health Education England on behalf of NHS England and the Department of Health in 2015.

 

The JCCP has now launched a new Corporate Membership Programme (CMP) which has been designed to enable commercial businesses and other stakeholders in the non-surgical cosmetic and hair restoration sector to work with the JCCP to improve and promote patient safety and public awareness of all aspects of the non-surgical aesthetics and hair restoration sector and to access a range of benefits and services to be provided by (and in association with) the JCCP.

 

The JCCP is delighted to announce its founder Corporate Members are –Church Pharmacy, Clinisept+, Irwin Mitchell, Hamilton Fraser, Merz, Teoxane and other non-disclosed corporate members.

 

At the initial meeting of the CMP it was agreed that the priority areas to focus on over the next 12 months are:

1. 1. Influencing potential changes to the regulatory framework governing the sector with a focus on patient safety and public protection linked to the outcome of the recommendations of the All-Party Parliamentary Group on Beauty, Aesthetics and Wellbeing.
2. 2. Clarification and the co-production of potential mandatory standards in relation to the training and development needs of practitioners to ensure patient safety and the implications for education and training providers.
3. 3. Identification and promotion of the role that CMP members can have in relation to raising public and consumer awareness of patient safety-related matters and best practice in the sector.
4. 4. Researching and developing new policies and actions in relation to key clinical issues linked to safe products, premises, ethical and safe prescribing and practitioners working with the JCCP Clinical Advisory Group and key partners.

The CMP members also agreed to consider how best their own resources could be combined with those of the JCCP to deliver:

Access to information relating to:

• • - Industry trends.
  • - Market intelligence and demographics.
  • - Registrants feedback on products/services purchased from commercial stakeholders.
  • - Distributor trends.
  • - Complications and adverse incidents linked to practitioner activity.
  • - Complications and adverse incidents linked to products.

 

Insights and Analysis of Regulatory Change and Professional Practice Provided by the JCCP from:

• • - Government departments – DHSC, DWP, Treasury etc
  • - Devolved authorities – Scotland, Wales and NI.
  • - Parliamentary Groups and Working Parties e.g. APPG on Beauty, Wellbeing and Aesthetics.
  • - Key regulatory bodies:
    • - CQC
    • - MHRA
    • - Health Care Statutory Regulators (GMC, NMC, GDC, HCPC, GPhC etc).
    • - Vocational Qualification Regulators – Ofqual, SQA etc.
    • - Professional Standards Authority (PSA).
    • - Environmental Health and Local Councils.
    • - Advertising Standards Authority.
  • - Professional Associations – BCAM, BACN, BAD, BAAPS, BAPRAS and others.
  • - Royal/National Colleges and Societies, such as the Royal Society for Public Health, The Chartered Institute for Environmental Health, the Mental Health Foundation, the British Beauty Council, Skills Active, BABTAC and Habia.
  • - Pharma Companies and Pharmacy Distributors.
  • - Insurance Companies.
  • - Data Processing organizations such as the CPSA, Northgate Public Services and ACE.

 

Access to debates and discussions around key clinical governance, patient safety and public protection issues:

• • - Membership/Affiliation of the JCCP Clinical Advisory Group (CAG).

 

Access to debates, information, research and papers looking at key issues including:

• • - Standards for defined modalities for clinically  determined treatments.
  • - Legal definitions around ‘medical’ and ‘cosmetic’ procedures.
  • - Complications and adverse event reporting.
  • - Data intelligence activity that generates new evidence to inform product development, testing, usage and after care and patient related demographic sampling/surveys.
  • - Safe prescribing practice.

 

Access to Information on trends and developments in education and training:

• • - Competency frameworks and qualifications linked to JCCP/CPSA standards.
  • - Data on education and training providers, qualifications and programmes.
  • - The CPD needs of practitioners and associated insurance requirements/indemnity levels.

 

Involvement with key regulatory campaign themes and activities:

• • - Campaigns aimed at practitioners.
  • - Campaign aimed at the promotion of excellence in education and training.
  • - Campaigns aimed at Government with regard to licensing, regulatory standards and enforcement.
  • - Campaigns aimed at patient safety, public protection and responding to members of the public.
  • - Campaigns aimed at the manufacture, supply and administration of safe medicines, devices and products.
  • - Campaigns aimed at the provision of safe premises.

 

Access to Practitioners and Industry Experts:

• • - Events
  • - Forums
  • - Working Groups
  • - Surveys.
  • - Annual conferences and webinars

 

Professor David Sines CBE – Executive Chair – JCCP said,

‘The JCCP has developed significantly over the last three years and has now broadened its role considerably beyond its important functions to hold registers for practitioners and for approved education and training providers. There is immense support for activities and structures that enable stakeholders across the whole of the non-surgical cosmetic and hair restoration sector to come together to gain access to industry information, share contacts/data and to collectively make the case for more extensive and fair regulation across all services to ensure patient safety.

 

‘The new JCCP Corporate Membership Programme provides the vehicle by which many commercial stakeholders can come together and pursue a set of shared objectives relating to patient safety and public protection – be it safe practitioners, safe products, safe premises and raising public awareness.  This is Year 1 of this exciting programme and we invite more stakeholders to join and influence the direction of the programme’.

 

For more information please contact:

admin@jccp.org.uk